Literature DB >> 34536320

Incidence and risk factors of female urinary incontinence: a 4-year longitudinal study among 24 985 adult women in China.

H Pang1, J Lv2, T Xu3, Z Li10, J Gong5, Q Liu6, Y Wang7, J Wang8, Z Xia9, Z Li10, L Li2, L Zhu10.   

Abstract

OBJECTIVE: To estimate the incidence of urinary incontinence (UI), including its subtypes stress UI (SUI), urgency UI (UUI) and mixed UI (MUI), and to examine risk factors for de novo SUI and UUI in Chinese women.
DESIGN: Nationwide longitudinal study.
SETTING: Six geographic regions of China. PARTICIPANTS: Women aged ≥20 years old were included using a multistage, stratified, cluster sampling method.
METHODS: This study was conducted between May 2014 and March 2016, with follow up in 2018. Data on demographics, medical history, lifestyle and physiological and anthropometric information were collected. MAIN OUTCOME MEASUREMENTS: Incidence, rate ratio (RR).
RESULTS: Analyses included 24 985 women (mean age 41.9 years).The follow-up response rate was 55.5%, median follow-up time was 3.7 years. The standardised incidences of UI, SUI, UUI and MUI were 21.2, 13.1, 3.0 and 5.1 per 1000 person-years, respectively. Risk factors for de novo SUI included delivery pattern (vaginal spontaneous delivery RR 2.12, 95% CI 1.62-2.78 and instrumental delivery RR 3.30, 95% CI 1.99-5.45), high body mass index (BMI) (overweight RR 1.52, 95% CI 1.33-1.74 and obesity RR 1.67, 95% CI 1.32-2.11), cigarette smoking (RR 1.54, 95% CI 1.12-2.12), chronic cough (RR 1.44, 95% CI 1.17-1.76), diabetes (RR 1.33, 95% CI 1.10-1.60) and older age (50-59 years RR 1.49, 95% CI 1.16-1.90 and 60-69 years RR 1.61, 95% CI 1.22-2.13).The risk factors significantly associated with de novo UUI were age (RR increased from 1.21, 95% CI 0.74-1.99, at 30-39 years to 6.3, 95% CI 3.85-10.30, at >70 years) and diabetes (RR 1.48, 95% CI 1.05-2.09).
CONCLUSIONS: The incidence of female UI is 21.2 per 1000 person-years in China. Delivery (vaginal spontaneous delivery, instrumental delivery), high BMI, cigarette smoking, chronic cough, diabetes and older age were risk factors. TWEETABLE ABSTRACT: The incidence of female urinary incontinence was 21.2 per 1000 person-years in China. Delivery, BMI, diabetes and old age are risk factors.
© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Female urinary incontinence; incidence rate; mixed urinary incontinence; risk factors; stress urinary incontinence; urgency urinary incontinence

Mesh:

Year:  2021        PMID: 34536320      PMCID: PMC9298368          DOI: 10.1111/1471-0528.16936

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   7.331


Introduction

Urinary incontinence (UI) is defined as the complaint of any involuntary leakage of urine, according to the International Continence Society. It is common in adult women, not life‐threatening but seriously affecting quality of life. The financial burden of UI is substantial, with estimated annual direct costs in the USA of $19.5 billion in 2000. The cost of UI is expected to increase dramatically as the population continues to age. Several epidemiological studies of female UI have been conducted in Western countries, with an estimated annual incidence varying from 1 to 11%, , , , , , and prevalence varying from 5 to 69%. , , This variability is related to differences in the definitions of UI used, the populations studied and different measuring instruments. , However, reliable estimation is required to plan effective clinical prevention and control. As China has a rapidly aging population, female UI is becoming an important public health concern. The available epidemiological evidence comes from cross‐sectional studies that were conducted across six regions of China among women ≥20 years of age in 2006. , , The findings showed that the prevalence of UI and its subtypes, including stress urinary incontinence (SUI), urgency urinary incontinence (UUI) and mixed urinary incontinence (MUI), were 30.9, 18.9, 2.6 and 9.4%, respectively. However, the incidence rate of female UI is still unclear in China. Furthermore, a few longitudinal studies in Western women showed that the risk factors were different between UI subtypes, with educational level, body mass index (BMI), race and depression for SUI, and alcohol consumption and surgery for UUI. , However, it remains unclear whether such associations hold among Chinese women. We aimed to estimate the incidence rate of female UI and its subtypes, including SUI, UUI and MUI, in a large‐scale population‐based longitudinal study in China. We further examined potential risk factors for de novo SUI and UUI.

Methods

Study design and participants

This study was a population‐based prospective study. A baseline survey with a multistage stratified cluster sampling design was conducted between May 2014 and January 2016. Details of the sampling technique, baseline recruitment and data collection have been described previously. In brief, six provinces of China, which represent six major geographic regions of great socio‐economic and cultural diversity, were randomly selected as study regions. These provinces were Gansu in the northwest, Guizhou in the southwest, Shanxi in central China, Liaoning in the northeast, Jiangsu in the east and Guangdong in the southeast. Three counties and three cities, which were stratified by levels of economic development and urbanisation, were randomly selected from each province. The target population was all eligible adult female residents according to the updated census lists from the community registry offices. The inclusion criteria were women ≥20 years old in the general population who had lived in the registered regions for at least 5 years before the study. Individuals with severe mental or physical illness and pregnant females were excluded. A total of 55 477 women aged ≥20 years participated in the baseline survey (central China: 9104, the northwest: 9723, the east: 9078, the southwest: 8774, the southeast: 9803, and the northeast: 8995). From June to December in 2018, we contacted 55 190 women who had complete baseline data for a telephone follow up, and 30 658 (55.5%) participants completed the follow‐up survey. We compared the baseline sociodemographic characteristics between responders and non‐responders (Table S1). Non‐responders were older and comprised a higher proportion of urban population compared with responders. After excluding 5675 participants who had UI detected at baseline or had missing data, a total of 24 985 women were eligible for final analysis. The study flowchart is shown in Figure 1.
Figure 1

Study flowchart.

Study flowchart. Ethical approval for the research protocol was obtained from the Institutional Review Board of Peking Union Medical College Hospital. Approval in the form of written informed consent was obtained from all participants.

Assessment of UI

Trained interviewers used the same self‐developed questionnaire in the baseline and follow‐up surveys. The participants were asked the following questions: (1) ‘During the last 6 months, did you leak urine when you were performing some physical activity, such as coughing, sneezing, lifting, or exercise?’ (no or yes); and (2) ‘During the last 6 months, did you leak urine when you had the urge or the feeling that you needed to empty your bladder, but you could not get to the toilet fast enough?’ (no or yes). The International Continence Society defines UI as the complaint of any involuntary leakage of urine. Women who answered yes for question (1) were categorised as having SUI (i.e. involuntary leakage on effort, exertion, sneezing or coughing). Women who answered yes for question (2) were categorised as having UUI (i.e. involuntary urine leakage accompanied by, or immediately preceded by, urgency). Women who answered yes for both questions were categorised as having MUI. Women with any of SUI, UUI or MUI were categorised as having UI.

Assessment of other variables

An interviewer‐administered questionnaire was also used to collect information on sociodemographic characteristics, physiological data, reproductive health, personal medical history, lifestyle behaviours and anthropometric data. Sociodemographic characteristics included birth year, ethnicity, marital status and education level. Information on reproductive health included menstruation, postmenopausal hormone replacement therapy and childbearing history. Medical history included doctor‐diagnosed chronic diseases (diabetes and cancers) and gynaecological diseases (pelvic inflammatory disease, pelvic pain, endometriosis, fibroids, gynaecological malignant tumours, pelvic organ prolapse). Lifestyle behaviours included smoking and alcohol drinking. Anthropometric data included weight and height.

Statistical analysis

Normally distributed continuous data are expressed as mean ± SD and non‐normally distributed continuous data are expressed as the median (25th centile, 75th centile). A test for normality was performed by the Shapiro–Wilk test. Categorical variables are presented as the number and proportion. Incidence rates per 1000 person‐years were obtained by dividing the total number of incident cases over the follow‐up period by the total observed person‐years and multiplying by 1000. The incidence rates were standardised by age and region using the population composition of those aged ≥20 years from the 2010 Chinese census population. We conducted tests for the linear trend of incidence rate across categories of age group. The multivariable Poisson regression model was used to assess the relationship between de novo SUI/UUI and potential risk factors of baseline and to estimate the rate ratio (RR) and 95% CI. We first performed univariate analysis to select statistically significant risk factors. We then combined these risk factors with clinical considerations for the multivariable model. Statistical significance for each variable in the model was analysed by the Wald test. All P values are two‐sided, with the significance level set at 0.1 for univariate analysis and 0.05 for other statistical tests. Data processing and statistical analyses were performed using SAS Version 9.3 (SAS, Cary, NC, USA).

Results

Among the 24 985 participants included in the analysis, the age distribution ranged from 20 to 96 years, and the median (25th centile, 75th centile) follow up was 3.7 (3.1, 4.1) years. The mean (± SD) age was 41.9 ± 15.0 years and mean BMI was 22.5 ± 3.0 kg/m². Overall, 12 994 (52.0%) participants were from urban areas. With regard to the delivery pattern, there were 15 736 (63.4%) vaginal spontaneous deliveries, 4331 (17.4%) caesarean sections, and 212 (0.9%) instrument‐assisted deliveries. Sociodemographic characteristics, physiological and pathological conditions, and health behaviour of study participants at baseline and follow up are shown in Table 1.
Table 1

Sociodemographic characteristics, physiological and pathological conditions, and health behaviour of the study participants at baseline and follow up

Characteristic

Baseline

n = 24 985

Follow up

n = 24 985

Age (years), mean ± SD41.9 ± 15.045.4 ± 14.9
20–296521 (26.1)3869 (15.5)
30–396517 (26.1)6795 (27.2)
40–495244 (21.0)5945 (23.8)
50–593010 (12.1)3890 (15.6)
60–691998 (8.0)2410 (9.7)
≥701695 (6.8)2076 (8.3)
Race
Han24 436 (97.9)24 436 (97.9)
Minority521 (2.1)521 (2.1)
Education
Primary school and below5454 (21.8)5605 (22.4)
Junior middle school6540 (26.2)5988 (24.0)
Senior school5663 (22.7)5734 (23.0)
College or above7318 (29.3)7648 (30.6)
Marital status
Couple21 614 (86.9)22 352 (90.2)
Single2382 (9.6)1390 (5.6)
Divorce/Widowed874 (3.5)1041 (4.2)
Cigarette smoking441 (1.8)272 (1.09)
Alcohol consumption151 (0.6)263 (1.06)
BMI (kg/m2), mean ± SD22.5 ± 3.022.6 ± 3.0
Underweight (<18.5)1747 (7.0)1429 (5.8)
Normal (18.5–23.9)16 523 (66.1)16 538 (66.5)
Overweight (24–27.9)5537 (22.2)5707 (23.0)
Obese (≥28)1175 (4.7)1192 (4.8)
Parity
Nulliparous4560 (18.3)2334 (9.3)
Primiparous (1)11 312 (45.5)11 536 (46.2)
Multiparous (2)5959 (24.0)7595 (30.4)
Multiparous (≥3)3034 (12.2)3513 (14.1)
Delivery pattern
Nulliparous4560 (18.4)2334 (9.4)
Vaginal spontaneous delivery15 736 (63.4)17 254 (69.5)
Instrumental deliverer212 (0.9)215 (0.9)
Caesarean section4331 (17.4)5032 (20.3)
Gynaecological disease* 5975 (24.0)3238 (13.04)
Premenopausal15 688 (71.8)14 174 (64.9)
Cough (>3 weeks)1385 (5.6)994 (4.0)
Diabetes2159 (8.7)2505 (10.1)
Pelvic surgery7606 (30.5)9973 (40.0)
Spinal surgery79 (0.3)116 (0.5)

Data are shown as mean ± SD or n (%).

Gynaecological diseases included myoma, pelvic inflammatory disease, chronic pelvic pain and endometriosis.

Sociodemographic characteristics, physiological and pathological conditions, and health behaviour of the study participants at baseline and follow up Baseline n = 24 985 Follow up n = 24 985 Data are shown as mean ± SD or n (%). Gynaecological diseases included myoma, pelvic inflammatory disease, chronic pelvic pain and endometriosis. Overall, the crude incidence rate of UI was 19.6 (95% CI 18.7–20.5) per 1000 person‐years among women aged ≥20 years (Table 2). The age‐specific incidence rate of UI rose significantly with age (P trend < 0.0001 for urban and rural areas) from 10.2 per 1000 person‐years in the 20–30 years group to 43.0 per 1000 person‐years in the >70 years group. The crude incidence rate was significantly higher in rural than in urban areas (21.0, 95% CI 19.6–22.3 versus 18.2, 95% CI 16.9–19.4 per 1000 person‐years, P < 0.0001). The standardised incidence rate of UI was 21.2 per 1000 person‐years for all women, and 19.5 and 23.0 per 1000 person‐years for urban and rural women, respectively.
Table 2

Incidence rate of female UI over 4 years by region and age*

Person‐yearsCasesIR (95% CI)Standardised IR (%)**, *
All89 790175719.6 (18.7–20.5)21.2
20–2922 59623010.2 (8.9–11.5)
30–3923 82133314.0 (12.5–15.5)
40–4919 90841020.6 (18.6–22.6)
50–5911 09430827.8 (24.7–30.9)
60–69680523734.8 (30.3–39.3)
≥70556423943.0 (37.5–48.4)
Urban45 14782018.2 (16.9–19.4)19.5
20–2912 0031048.7 (7.0–10.3)
30–3912 65716112.7 (10.8–14.7)
40–49958318919.7 (16.9–22.5)
50–59492315130.7 (25.8–35.6)
60–69340911634.0 (27.8–40.2)
≥7025739938.5 (30.9–46.1)
Rural44 64393721.0 (19.6–22.3)23.0
20–2910 59312611.9 (9.8–14.0)
30–3911 16417215.4 (13.1–17.7)
40–4910 32622121.4 (18.6–24.2)
50–59617115725.4 (21.5–29.4)
60–69339712135.6 (29.3–42.0)
≥70299114046.8 (39.1–54.6)

Incidence rate (IR) per 1000 person‐years.

Standardised incidence rate: the incidence rates were standardised by age and region based on the 2010 Chinese census.

Incidence rate of female UI over 4 years by region and age* Incidence rate (IR) per 1000 person‐years. Standardised incidence rate: the incidence rates were standardised by age and region based on the 2010 Chinese census. For subtypes of UI, the crude incidence rates of female SUI, UUI and MUI were 12.4 (95% CI 11.7–13.2), 2.7 (95% CI 2.4–3.0) and 4.4 (95% CI 4.0–4.9) per 1000 person‐years, respectively. The trend of the incidence rates of SUI, UUI and MUI with age is shown in Figure S1. For SUI, the crude incidence initially increased and then decreased with age, and peaked at 60–69 years (Table 3). The crude incidence of UUI and MUI monotonically increased with age, especially in the age group of >70 years, which was much higher than other age groups (P < 0.0001). This pattern was found in urban (P < 0.0001) and rural areas (P < 0.0001) (Table 3). With regard to different delivery patterns, the incidence rates of SUI in women who were nulliparous, and in those who had vaginal spontaneous delivery, instrumental delivery and caesarean section were 5.9, 15.1, 27.7 and 8.9 per 1000 person‐years, respectively. The incidence rates of UI, SUI and UUI increased with BMI (P trend < 0.05) (Figure 2). The standardised incidence rates of SUI, UUI and MUI were 13.1, 3.0 and 5.1 per 1000 person‐years, respectively.
Table 3

Incidence rates of female UI subtypes over 4 years by region and age*

RegionPerson‐yearsSUIUUIMUI
CasesIR (95% CI)Standardised IR (%)** CasesIR (95% CI)Standardised IR (%)** CasesIR (95% CI)Standardised IR (%)**
All89 790111712.4 (11.7–13.2)13.12432.7 (2.4–3.0)3.03974.4 (4.0–4.9)5.1
20–2922 5961787.9 (6.7–9.0)281.2 (0.8–1.7)241.1 (0.6–1.5)
30–3923 82124510.3 (9.0–11.6)361.5 (1.0–2.0)522.2 (1.6–2.8)
40–4919 90827213.7 (12.0–15.3)502.5 (1.8–3.2)884.4 (3.5–5.3)
50–5911 09419517.6 (15.1–20.0)423.8 (2.6–4.9)716.4 (4.9–7.9)
60–69680513519.8 (16.5–23.2)345.0 (3.3–6.7)6810.0 (7.6–12.4)
≥7055649216.5 (13.2–19.9)539.5 (7.0–12.1)9416.9 (13.5–20.3)
Urban45 14754312.0 (11.0–13.0)12.61072.4 (1.9–2.8)2.61703.8 (3.2–4.3)4.2
20–2912 003836.9 (5.4–8.4)141.2 (0.6–1.8)70.6 (0.2–1.0)
30–3912 6571249.8 (8.1–11.5)141.1 (0.5–1.7)231.8 (1.1–2.6)
40–49958313313.9 (11.5–16.2)202.1 (1.2–3.0)363.8 (2.5–5.0)
50–5949239719.7 (15.8–23.6)193.9 (2.1–5.6)357.1 (4.8–9.5)
60–6934097020.5 (15.7–25.3)164.7 (2.4–7.0)308.8 (5.7–11.9)
≥7025733614.0 (9.4–18.6)249.3 (5.6–13.1)3915.2 (10.4–19.9)
Rural44 64357412.9 (11.8–13.9)13.61363.0 (2.5–3.6)3.52275.1 (4.4–5.7)6.0
20–2910 593959.0 (7.2–10.8)141.3 (0.6–2.0)171.6 (0.8–2.4)
30–3911 16412110.8 (8.9–12.8)222.0 (1.1–2.8)292.6 (1.7–3.5)
40–4910 32613913.5 (11.2–15.7)302.9 (1.9–3.9)525.0 (3.7–6.4)
50–5961719815.9 (12.7–19.0)233.7 (2.2–5.3)365.8 (3.9–7.7)
60–6933976519.1 (14.5–23.8)185.3 (2.9–7.7)3811.2 (7.6–14.7)
≥7029915618.7 (13.8–23.6)299.7 (6.2–13.2)5518.4 (13.5–23.2)

Incidence rate (IR)/1000 person‐years.

Standardised incidence rate: the incidence rates were standardised by age and region based on the 2010 Chinese census.

Figure 2

BMI‐specific incidence rate of UI and its subtypes. Trend test: UI: P < 0.0001; SUI: P < 0.0001; UUI: P = 0.011; MUI: P < 0.0001.

Incidence rates of female UI subtypes over 4 years by region and age* Incidence rate (IR)/1000 person‐years. Standardised incidence rate: the incidence rates were standardised by age and region based on the 2010 Chinese census. BMI‐specific incidence rate of UI and its subtypes. Trend test: UI: P < 0.0001; SUI: P < 0.0001; UUI: P = 0.011; MUI: P < 0.0001. Univariate and multivariable analyses of the risk factors of developing SUI are shown in Table 4. In multivariable analysis, middle and older age, higher BMI, race, higher education, vaginal spontaneous delivery, instrumental delivery, chronic cough, diabetes and cigarette smoking were identified as risk factors for de novo SUI (P < 0.05). Our study showed a higher risk of SUI in middle‐aged and older‐aged women (RR 1.49, 95% CI 1.16–1.90 for 50–59 years, RR 1.61, 95% CI 1.22–2.13 for 60–69 years) compared with young women (20–29 years). Women who were overweight (RR 1.52, 95% CI 1.33–1.74) and with obesity (RR 1.67, 95% CI 1.32–2.11) were more likely to have SUI than women with a normal BMI. With regard to delivery pattern, women with vaginal spontaneous delivery (RR 2.12, 95% CI 1.62–2.78) and instrumental delivery (RR 3.30, 95% CI 1.99–5.45) were more likely to have SUI than nulliparous women.
Table 4

Univariate and multivariable adjusted rate ratios (95% CI) for the risk of developing SUI

VariablesUnivariate analysisMultivariable analysis
RR (95% CI) P valueRR (95% CI) P value
Age (years)
20–29ReferenceReference
30–391.31 (1.08–1.58)0.0070.99 (0.79–1.23)0.930
40–491.73 (1.44–2.10)<0.00011.22 (0.97–1.54)0.083
50–592.23 (1.82–2.73)<0.00011.49 (1.16–1.90)0.002
60–692.52 (2.01–3.15)<0.00011.61 (1.22–2.13)0.001
≥702.10 (1.63–2.70)<0.00011.33 (0.98–1.82)0.069
Region
UrbanReference
Rural1.07 (0.95–1.20)0.265
Race
HanReferenceReference
Minority0.41 (0.21–0.79)0.0070.46 (0.24–0.89)0.022
Education
Primary school and belowReferenceReference
Junior middle school1.28 (1.08–1.51)0.0041.66 (1.40–1.98)<0.0001
Senior school1.01 (0.84–1.21)0.9201.59 (1.30–1.94)<0.0001
College or above0.99 (0.83–1.18)0. 9102.05 (1.68–2.52)<0.0001
Cigarette smoking2.05 (1.50–2.80)<0.00011.54 (1.12–2.12)0.007
Alcohol consumption0.43 (0.14–1.34)0.146
BMI (kg/m2)
Underweight (<18.5)0.79 (0.59–1.04)0.0970.90 (0.67–1.20)0.470
Normal (18.5–23.9)ReferenceReference
Overweight (24.0–27.9)1.75 (1.53–1.99)<0.00011.52 (1.33–1.74)<0.0001
Obese (≥28.0)1.89 (1.50–2.37)<0.00011.67 (1.32–2.11)<0.0001
Marital status
CoupleReference
Single0.37 (0.27–0.51)<0.0001
Divorce/Widowed1.40 (1.07–1.82)0.01
Delivery pattern
NulliparousReferenceReference
Vaginal spontaneous delivery2.54 (2.05–3.14)<0.00012.12 (1.62–2.78)<0.0001
Instrumental delivery4.67 (2.91–7.50)<0.00013.30 (1.99–5.45)<0.0001
Caesarean section1.49 (1.15–1.94)0.0031.28 (0.95–1.71)0.107
Gynaecological disease*, * 1.09 (0.95–1.23)0.253
Premenopausal1.45 (1.28–1.64)<0.0001
Cough (>3 weeks)1.64 (1.34–2.01)<0.00011.44 (1.17–1.76)0.001
Diabetes1.98 (1.68–2.33)<0.00011.33 (1.10–1.60)0.003
Pelvic surgery0.87 (0.77–0.99)0.039
Spinal surgery0.55 (0.14–2.20)0.397

Gynaecological diseases included myoma, pelvic inflammatory disease, chronic pelvic pain and endometriosis.

Univariate and multivariable adjusted rate ratios (95% CI) for the risk of developing SUI Gynaecological diseases included myoma, pelvic inflammatory disease, chronic pelvic pain and endometriosis. Univariate and multivariable analyses of the risk factors of developing UUI are shown in Table 5. The risk factors that were positively associated with de novo UUI were older age and diabetes. The RR of UUI increased with age, from 1.96 (95% CI 1.24–3.12) in the 40–49 years group to 6.30 (95% CI 3.85–10.30) in the >70 years group compared with the 20–29 years group.
Table 5

Univariate and multivariable adjusted rate ratios (95% CI) for the risk of developing UUI

VariablesUnivariate analysisMultivariable analysis
RR (95% CI) P valueRR (95% CI) P value
Age (years)
20–29ReferenceReference
30–391.22 (0.74–2.00)0.4311.21 (0.74–1.99)0.442
40–492.03 (1.28–3.22)0.0031.96 (1.24–3.12)0.004
50–593.06 (1.89–4.93)<0.00012.81 (1.73–4.56)<0.0001
60–694.03 (2.44–6.65)<0.00013.47 (2.06–5.84)<0.0001
≥707.69 (4.86–12.15)<0.00016.30 (3.85–10.30)<0.0001
Region
UrbanReference
Rural1.28 (1.00–1.66)0.052
Race
HanReference
Minority1.27 (0.57–2.86)0.561
Education
Primary school and belowReference
Junior middle school0.74 (0.54–1.01)0.061
Senior school0.64 (0.46–0.91)0.013
College or above0.28 (0.18–0.42)<0.0001
Cigarette smoking0.67 (0.21–2.09)0.491
Alcohol consumption1.33 (0.33–5.33)0.692
BMI (kg/m2)
Underweight (<18.5)0.92 (0.53–1.60)0.778
Normal (18.5–23.9)Reference
Overweight (24.0–27.9)1.44 (1.08–1.91)0.012
Obese (≥28.0)1.45 (0.85–2.46)0.173
Marital status
CoupleReference
Single0.35 (0.17–0.72)0.004
Divorce/Widowed2.28 (1.44–3.60)<0.0001
Delivery pattern
NulliparousReference
Vaginal spontaneous delivery3.65 (2.12–6.28)<0.0001
Instrumental delivery4.38 (1.26–15.35)0.020
Caesarean section2.48 (1.34–4.61)0.004
Gynaecological disease** 1.09 (0.82–1.45)0.556
Premenopausal3.78 (2.87–4.99)<0.0001
Cough (>3 weeks)0.82 (0.46–1.46)0.499
Diabetes3.14 (2.33–4.24)<0.00011.48 (1.05–2.09)0.026
Pelvic surgery1.00 (0.76–1.30)0.972
Spinal surgery2.53 (0.63–10.19)0.190

Gynaecological diseases included myoma, pelvic inflammatory disease, chronic pelvic pain and endometriosis.

Univariate and multivariable adjusted rate ratios (95% CI) for the risk of developing UUI Gynaecological diseases included myoma, pelvic inflammatory disease, chronic pelvic pain and endometriosis.

Discussion

Main findings

The current nationwide longitudinal survey included 24 985 women. We found that standardised incidence rates of UI, SUI, UUI and MUI were 21.2, 13.1, 3.0 and 5.1 per 1000 person‐years, respectively, among adult women in China. Delivery (vaginal spontaneous delivery, instrumental delivery), high BMI, cigarette smoking, chronic cough, diabetes, middle and older age, and living in rural areas increase the risk of SUI. Older age and diabetes increase the risk of UUI.

Strengths and limitations

The strengths of this study are that it included a large population of women, which enabled us to accurately estimate the incidence of UI in each subgroup. Furthermore, for the first time, the incidence rate of female UI and its subtypes has been reported in the general population in China, especially for young women. Finally, several controllable risk factors were identified for de novo SUI and UUI. Our study has several limitations. First, because 44.5% participants did not respond in the follow‐up survey, selection bias due to loss to follow up was inevitable. However, the distributions of baseline characteristics between the responders and the non‐responders were similar. Although the differences were significant in this large sample, the absolute differences were small, so we believe that loss to follow up did not have a great impact on the estimation of incidence rate. Second, all information was obtained through self‐reporting of responders. Therefore, information bias might have affected the accuracy of the data. Third, UI is a dynamic process and not necessarily progressive, and some people may have recovered before follow up. Therefore, the incidence of UI may have been underestimated. Finally, the frequency and volume of urine leakage and its impact on quality of life were not measured, which makes it impossible to know the severity of UI and the bother it causes to women. A certain proportion of women with symptoms of urine leakage may never require treatment. Further evidence on the severity of UI in women of different ages is needed in future studies.

Interpretation

This study showed that the standardised incidence of UI was 21.2 per 1000 person‐years, which approaches the lower range of estimates from other studies, which ranged from 1 to 11%. Our results of incidence in people aged >60 years are similar to that of the SABE STUDY, which showed the incidence of UI was 39.3 per 1000 person‐years among a relatively small sample size of 864 Brazilian older women (individuals aged ≥60 years). An analysis of the Nurses' Health Study cohort, which included 852 Asian women aged 37–79 years in the USA, showed that the incidence of UI in Asian women was 5.7 per 100 person‐years. This number is higher than that of our result in women aged >40 years, perhaps because the participants of the Nurses' Health Study cohort are specifically a highly educated population. Additionally, our result is lower than that of Espuna‐Pons et al.’s study, which showed that the 1‐year incidence of female UI was 5.3% in the age group of 18–91 years in patients seeking care for different gynaecological problems in Spain. Although the participants came from the clinical population, the incidence of female UI may have been higher than that in the general population. The French GAZEL cohort study recruited 4127 middle‐aged (47–52 years old at baseline) women over 18 years (1990–2008), and reported an annual incidence of 3.3% for UI, which is higher than that of our result in women aged 40–60 years. Although several studies have reported the incidence of female UI in various populations, these earlier findings are not comparable because of the small sample size or non‐representative samples or clinical patients. , , , Identifying risk factors is important for clinical prevention and decision‐making. Because MUI is a combination of SUI and UUI, and MUI pathophysiology may be different from that of pure SUI and pure UUI combined together, we focused on analysing the risk factors of SUI and UUI. Our findings suggested that vaginal spontaneous delivery and instrumental delivery significantly increased the risk of SUI, which is consistent with previous studies. , Vaginal delivery is correlated with development of SUI, probably via injury of pelvic floor structures, such as muscles, nerves, organs and the extracellular matrix responsible for continence. Tahtinen et al. showed that instrumental delivery, especially forceps delivery, is associated with significant increased long‐term risk of SUI compared with other vaginal deliveries for women aged ≤50 years. More attention needs to be paid to women after childbirth, and early prevention and rehabilitation strategies for SUI are required. Our study showed that BMI at baseline was significantly associated with SUI. These data confirm the associations found between weight gain and UI in clinical patients. However, we did not find an association between BMI and UUI. BMI is a risk factor that can have intervention, and moderate weight reduction may be beneficial for treatment and prevention of SUI. Age is an established risk factor for SUI and UUI. , , Our findings further confirmed that the risk of SUI and UUI increased with age in the general population. In each age group, although the risk of UUI was higher than that of SUI, the prevalence of SUI was higher. Therefore, the absolute number involved in SUI was more than that of UUI. The incidence of UI subtypes in women aged >60 years is increasing rapidly, which requires more investment in clinical treatment. We also found a significant association between diabetes and the incidence of SUI and UUI. Although diabetes was identified as a risk factor for UI in a previous cross‐sectional study, our results indicated its causal association by time in our prospective study. Our study suggests that health management of chronic diseases, such as obesity and diabetes, may help to reduce the risk of SUI and UUI. Our study findings have important public health implications. We calculated the absolute numbers of people with SUI based on the number of Chinese women from the 2018 Chinese Statistics Yearbook. The estimated total number of individuals aged ≥20 years with de novo UI was 14.46 million in China, including 8.93 million SUIs, 2.05 million UUIs and 3.48 million MUIs. With rapid entry into an aging society, the number of affected people and the burden of UI are anticipated to continue to increase in China. Our findings suggest the need for national policies and programmes for prevention and early detection of UI. Information about UI should be disseminated to the Chinese public to assure proper clinical treatment in the future.

Conclusion

Our study shows that the incidence of de novo female UI is 21.2/1000 person‐years in China. Delivery (vaginal spontaneous delivery, instrumental delivery), high BMI, cigarette smoking, chronic cough, diabetes, middle and older age, and living in rural areas increase the risk of SUI. Older age and diabetes increase the risk of UUI. Our findings may aid in identifying populations at risk, and help clinical early prevention, and intervention of UI.

Disclosure of interests

None declared. Completed disclosure of interest forms are available to view online as supporting information.

Contribution to authorship

LZ contributed to the study conception, design, analysis and interpretation of the data, and reviewed and approved the final manuscript. HP contributed to the study concept and design, analysis and interpretation of the data, and drafting of the manuscript. JL contributed to analysis and made critical revision of the manuscript. TX contributed to study concept and design. Zhaoai Li, JG, QL, YW, JW, ZX, and Zhiyi Li contributed to acquisition of data. LL made critical revision of the manuscript for important intellectual content.

Details of ethics approval

The study protocol was approved by the institutional review board of Peking Union Medical College Hospital (Number: S‐689, Date: 15 May 2014). The study protocol was approved (http://www.chictr.org, ChiCTR‐OCH‐14004675), and written informed consent was obtained from each participant before data collection.

Funding

This study was funded by the National Key R&D Programme of China (2018YFC2002201), the National Natural Science Foundation of China (72104247), the CAMS Initiative for Innovative Medicine (2017‐I2M‐1‐002) and the National Natural Science Foundation of China (81830043).

Acknowledgements

We thank all patients who participated in the study. We thank Ellen Knapp for editing the English text of a draft of this manuscript. Table S1. Baseline description of responders and non‐responders. Figure S1. Trend of the incidence rates of SUI, UUI and MUI with age. Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file. Supplementary Material Click here for additional data file.
  29 in total

1.  A populational-based survey on the prevalence, incidence, and risk factors of urinary incontinence in older adults-results from the "SABE STUDY".

Authors:  José Tadeu Nunes Tamanini; Letícia Valério Pallone; Marair Grácio Ferreira Sartori; Manoel João Batista Castello Girão; Jair Lício Ferreira Dos Santos; Yeda Aparecida de Oliveira Duarte; Philip E V A van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2017-06-30       Impact factor: 2.696

2.  Incidence and remission of stress, urge, and mixed urinary incontinence in midlife and older women: A longitudinal cohort study.

Authors:  Guillaume Legendre; Xavier Fritel; Henri Panjo; Marie Zins; Virginie Ringa
Journal:  Neurourol Urodyn       Date:  2019-11-27       Impact factor: 2.696

3.  Correlates of 1-year incidence of urinary incontinence in older Latino adults enrolled in a community-based physical activity trial.

Authors:  Shelby N Morrisroe; Larissa V Rodriguez; Pin-Chieh Wang; Ariana L Smith; Laura Trejo; Catherine A Sarkisian
Journal:  J Am Geriatr Soc       Date:  2014-03-11       Impact factor: 5.562

4.  Weight loss to treat urinary incontinence in overweight and obese women.

Authors:  Leslee L Subak; Rena Wing; Delia Smith West; Frank Franklin; Eric Vittinghoff; Jennifer M Creasman; Holly E Richter; Deborah Myers; Kathryn L Burgio; Amy A Gorin; Judith Macer; John W Kusek; Deborah Grady
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

5.  Incidence and remission of urinary incontinence at midlife: a cohort study.

Authors:  G Legendre; V Ringa; H Panjo; M Zins; X Fritel
Journal:  BJOG       Date:  2014-07-24       Impact factor: 6.531

6.  Urinary incontinence in French women: prevalence, risk factors, and impact on quality of life.

Authors:  Andrea Lasserre; Camille Pelat; Violaine Guéroult; Thomas Hanslik; Emmanuel Chartier-Kastler; Thierry Blanchon; Calin Ciofu; Emmanuel D Montefiore; Fabián P Alvarez; Juliette Bloch
Journal:  Eur Urol       Date:  2009-04-10       Impact factor: 20.096

Review 7.  Prevalence, incidence and obstetric factors' impact on female urinary incontinence in Europe: a systematic review.

Authors:  Maria Angela Cerruto; Carolina D'Elia; Alberto Aloisi; Miriam Fabrello; Walter Artibani
Journal:  Urol Int       Date:  2012-08-03       Impact factor: 2.089

8.  Costs of urinary incontinence and overactive bladder in the United States: a comparative study.

Authors:  Teh-Wei Hu; Todd H Wagner; Judith D Bentkover; Kristi Leblanc; Steve Z Zhou; Timothy Hunt
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

9.  Epidemiology of mixed, stress, and urgency urinary incontinence in middle-aged/older women: the importance of incontinence history.

Authors:  Yuko M Komesu; Ronald M Schrader; Loren H Ketai; Rebecca G Rogers; Gena C Dunivan
Journal:  Int Urogynecol J       Date:  2015-12-15       Impact factor: 2.894

10.  Incidence and risk factors of female urinary incontinence: a 4-year longitudinal study among 24 985 adult women in China.

Authors:  H Pang; J Lv; T Xu; Z Li; J Gong; Q Liu; Y Wang; J Wang; Z Xia; Z Li; L Li; L Zhu
Journal:  BJOG       Date:  2021-10-17       Impact factor: 7.331

View more
  5 in total

1.  Toileting behaviors, urinary cues, overactive bladder, and urinary incontinence in older women.

Authors:  Kathleen A O'Connell; Taylor B Nicholas; Mary H Palmer
Journal:  Int Urogynecol J       Date:  2022-05-19       Impact factor: 1.932

2.  Remission and Transition of Female Urinary Incontinence and Its Subtypes and the Impact of Body Mass Index on This Progression: A Nationwide Population-Based 4-Year Longitudinal Study in China.

Authors:  Haiyu Pang; Tao Xu; Zhaoai Li; Jian Gong; Qing Liu; Yuling Wang; Juntao Wang; Zhijun Xia; Lan Zhu
Journal:  J Urol       Date:  2022-04-15       Impact factor: 7.600

3.  Clinical Study on the Treatment of Female Stress Urinary Incontinence With Modified Buzhong Yiqi Decoction.

Authors:  Feifei Zhou; Chen Chen; Jiani Shi; Qianru Zhou; Lijun Jin; Xiaofang Ma
Journal:  Front Surg       Date:  2022-04-13

Review 4.  Does electroacupuncture benefit mixed urinary incontinence? A systematic review and meta-analysis with trial sequential analysis.

Authors:  Yang Cui; Quan Li; Delong Wang; Rui Bao; Limiao Li; Jiamin Zhu; Jianuo Li; Zhuxin Li; Jiantao Yin; Xinyu Zhou; Hongna Yin; Zhongren Sun
Journal:  Int Urogynecol J       Date:  2022-01-28       Impact factor: 1.932

5.  Incidence and risk factors of female urinary incontinence: a 4-year longitudinal study among 24 985 adult women in China.

Authors:  H Pang; J Lv; T Xu; Z Li; J Gong; Q Liu; Y Wang; J Wang; Z Xia; Z Li; L Li; L Zhu
Journal:  BJOG       Date:  2021-10-17       Impact factor: 7.331

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.